Search Results 131-140 of 17911 for crohns disease

  1. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    Crohn's disease or ulcerative colitis (not IC); <18 years old at the time of IBD diagnosis. Aims 1b-2: Enrolled and consented in ImproveCareNow; Crohn's ...

  2. The increasing prevalence of inflammatory bowel disease - Mayo Clinic News Network

    William Faubion Jr., a Mayo Clinic gastroenterologist, says inflammatory bowel disease is an umbrella term that covers Crohn's disease and ulcerative colitis, ...

  3. Bowel Disease Increases Risk for Stroke and Heart Attack - Mayo Clinic News Network

    ... disease in patients with IBD ... More than 1.5 million Americans have Crohn's disease or ulcerative colitis, the most common forms of inflammatory bowel disease.

  4. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

  5. Immuno-Epigenetics: William A. Faubion Jr.

    ... diseases (IBDs), such as Crohn's disease (CD) and ulcerative colitis (UC). Despite some genetic variation associated with IBD , environmental factors also ...

  6. Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease - Mayo Clinic

    The purpose of this study is to determine the effectiveness of RPC1063 in the initial treatment of moderate to severely active Crohn's disease. Participation ...

  7. Stem Cell Coated Fistula Plug in Patients With Crohn's RVF - Mayo Clinic

    ... Crohn's disease. Autologous means that these cells that coat the plug come from you. You will be in this study for two years. There is potential to continue ...

  8. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  9. Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

  10. Infliximab (intravenous route) - Mayo Clinic

    ... Crohn disease or ulcerative colitis in children 6 years of age and older. However, safety and efficacy have not been established in children younger than 6 ...